Samwel Mikaye: Understanding D-Dimer in Clinical Practice
Samwel Mikaye, Medical Doctor at MSK, shared a post on LinkedIn:
”What is D-Dimer?
D-dimer is a protein fragment produced when a blood clot is broken down in the body. It is normally undetectable or very low in the blood, but levels rise when the body forms and breaks down clots.
It is used primarily as a lab test to help rule out clotting disorders.
Common Uses of D-Dimer Test
- Suspected Deep Vein Thrombosis (DVT) – Clots in deep veins, usually in legs.
- Pulmonary Embolism (PE) – Clots in the lungs.
- Disseminated Intravascular Coagulation (DIC) – Abnormal widespread clotting and bleeding.
- Sometimes used to monitor clot breakdown in known clotting conditions.
Interpretation
- Normal/Low D-dimer → Clotting disorder unlikely.
- High D-dimer → Suggests recent or ongoing clot formation and breakdown, but not specific. Many conditions can raise D-dimer:
- Infection
- Inflammation
- Recent surgery or trauma
- Liver disease
- Cancer
Important: A high D-dimer does not confirm a clot. Imaging (like Doppler ultrasound or CT scan) is usually needed to diagnose DVT or PE.
Advantages
- Quick blood test.
- Good for ruling out clots in low-risk patients.
Limitations
- Non-specific – many conditions can raise it.
- Not useful alone to diagnose a clot.
- Less reliable in elderly patients or those with chronic illnesses.
Think of D-dimer as a ‘smoke alarm’: a high level signals something may be wrong with clotting, but you need further tests to find the fire (actual clot).”

Other posts featuring Samwel Mikaye on Hemostasis Today.
-
Mar 19, 2026, 15:34Kanishk Kumar: Wiskott-Aldrich Syndrome Pipeline Outlook Report 2026
-
Mar 19, 2026, 15:29Riten Kumar: Diagnosis and Management of Post-Thrombotic Sequelae Following Non-Extremity VTE in Children
-
Mar 19, 2026, 15:25Tom Rifai: Menopause as a Critical Window for Cardiometabolic Prevention
-
Mar 19, 2026, 15:16Glen Pyle: Association Between Premature Menopause and Coronary Heart Disease Risk
-
Mar 19, 2026, 15:14Georgiana Toma: Addressing Iron Deficiency Without Anemia
-
Mar 19, 2026, 15:01Erik Nelson: The Biomarker that Connects Heart, Brain, and DNA
-
Mar 18, 2026, 16:34Richard Buka: Exploring the COBRRA Trial in the Latest Episode of Don’t Just Read the Abstract
-
Mar 18, 2026, 16:22Heghine Khachatryan: Navigating the New Era of Hemophilia Gene Therapy
-
Mar 18, 2026, 16:21Georges Chahoud: Top Take-Home Messages from the AHA/ACC/Multisociety Acute PE Guideline